Your browser doesn't support javascript.
loading
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
Mani, Shailendra; Kaur, Anupamjeet; Jakhar, Kamini; Kumari, Geetika; Sonar, Sudipta; Kumar, Amit; Das, Sudesna; Kumar, Santosh; Kumar, Vijay; Kundu, Rakesh; Pandey, Anil Kumar; Singh, Umesh Prasad; Majumdar, Tanmay.
Affiliation
  • Mani S; Translational Health Science and Technology Institute, Faridabad, India.
  • Kaur A; National Institute of Immunology, New Delhi, India.
  • Jakhar K; Translational Health Science and Technology Institute, Faridabad, India.
  • Kumari G; National Institute of Immunology, New Delhi, India.
  • Sonar S; Translational Health Science and Technology Institute, Faridabad, India.
  • Kumar A; National Institute of Immunology, New Delhi, India.
  • Das S; CSIR-Indian Institute of Chemical Biology, Kolkata, India.
  • Kumar S; National Institute of Immunology, New Delhi, India.
  • Kumar V; National Institute of Immunology, New Delhi, India.
  • Kundu R; Department of Zoology, Visva-Bharati University, Santiniketan, West Bengal, India.
  • Pandey AK; Department of Physiology, ESIC Medical College & Hospital, Faridabad, India.
  • Singh UP; CSIR-Indian Institute of Chemical Biology, Kolkata, India.
  • Majumdar T; National Institute of Immunology, New Delhi, India. Electronic address: majumdart@nii.ac.in.
Int J Biol Macromol ; 245: 125444, 2023 Aug 01.
Article in En | MEDLINE | ID: mdl-37385308

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Int J Biol Macromol Year: 2023 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Int J Biol Macromol Year: 2023 Document type: Article Affiliation country: India